PHARMA & LIFE SCIENCES: LATEST INTERVIEWS MORE INTERVIEWS

AGC Biologic’s explains its expansion in the US.
"Our fixed-price, fastest DNA-to-IND program is packaged in a standardized platform to allow clients to bring a new antibody molecule to IND filing in a rapid amount of time."
Piramal Pharma Solutions comments on its continued global expansion.
Aragen Life Sciences explains how its expansion in both India and US can benefit drug discovery companies.

PHARMA & LIFE SCIENCES: LATEST ARTICLES

Funding Environment: Life Sciences Enter the Mainstream

April 20, 2021
The past 12 months been transformative for the life science industry in USA, and GBR explores how the funding environment has evolved to provide the influx of capital to sustain its innovations.

Turkey Pharmaceuticals: Bringing All Actors Together

June 17, 2020
Industry, university, investors - the two-way bridge to the knowledge gap.

PHARMA & LIFE SCIENCES: RECENTLY RELEASED PUBLICATIONS

MACIG

SUBSCRIBE TO OUR NEWSLETTER

RECENTLY PUBLISHED

Chile Mining 2022 - Digital Version

PARTNER EVENTS